GSK plc (LON:GSK) Insider Purchases £111.92 in Stock

GSK plc (LON:GSK) insider Julie Brown purchased 8 shares of GSK stock in a transaction dated Monday, November 11th. The stock was bought at an average price of GBX 1,399 ($18.00) per share, for a total transaction of £111.92 ($144.02).

GSK Price Performance

LON GSK opened at GBX 1,353.50 ($17.42) on Friday. The company has a debt-to-equity ratio of 123.04, a quick ratio of 0.73 and a current ratio of 0.82. GSK plc has a 52-week low of GBX 1,343.50 ($17.29) and a 52-week high of GBX 1,823.50 ($23.47). The business has a 50 day simple moving average of GBX 1,501.32 and a 200 day simple moving average of GBX 1,579.90. The stock has a market cap of £55.22 billion, a price-to-earnings ratio of 1,197.79, a PEG ratio of 1.24 and a beta of 0.31.

GSK Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, November 14th will be issued a dividend of GBX 15 ($0.19) per share. The ex-dividend date is Thursday, November 14th. This represents a dividend yield of 1.03%. GSK’s payout ratio is 5,309.73%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Berenberg Bank reissued a “buy” rating and issued a GBX 1,820 ($23.42) target price on shares of GSK in a research note on Tuesday, September 10th. Shore Capital reissued a “buy” rating on shares of GSK in a research note on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,850 ($23.81) target price on shares of GSK in a research note on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. reissued an “underweight” rating on shares of GSK in a research report on Monday, July 29th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,842.50 ($23.71).

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.